November 11 (SeeNews) - Romanian pharmaceuticals group A&D Pharma posted a 3.0% drop in its unaudited consolidated sales to 364.6 million euro ($548.5 million) through September despite a 16% depreciation year-on-year of the local currency leu against the euro, its parent, Dutch-based A&D Pharma Holdings N.V., said on Wednesday.